Rules and Regulations. Final rule

Agency: Food and Drug Administration, HHS
Action: Final rule
Citation: FR Doc. 03-359 · 21 CFR 510

Summary

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect a change of sponsor's name from Micro Chemical, Inc., to Micro Beef Technologies LTD and to correct the sponsor's mailing address.

Dates

This rule is effective January 9, 2003.

Supplementary Information

Micro Chemical, Inc., Amarillo, TX 79105, has informed FDA of a change of name and mailing address to Micro Beef Technologies LTD, P.O. Box 9262, Amarillo, TX 79105. Accordingly, the agency is amending the regulations in 21 CFR 510.600(c) to reflect these changes. This rule does not meet the definition of “rule” in 5 U.S.C. 804(3)(A) because it is a rule of “particular applicability.” Therefore, it is not subject to the congressional review requirements in 5 U.S.C. 801-808. List of Subjects in 21 CFR Part 510 Administrative practice and procedure, Animal drugs, Labeling, Reporting and recordkeeping requirements. Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR part 510 is amended as follows: PART 510—NEW ANIMAL DRUGS 1. The authority citation for 21 CFR part 510 continues to read as follows: Authority: 21 U.S.C. 321, 331, 351, 352, 353, 360b, 371, 379e. 2. Section 510.600 is amended in the table in paragraph (c)(1) by revising the entry for “Micro Chemical, Inc.” and in the table in paragraph (c)(2) by revising the entry for “047126” to read as follows: § 510.600 Names, addresses, and drug labeler codes of sponsors of approved applications. (c) * * * (1) * * * Firm name and address Drug labeler code * * * * * Micro Beef Technologies LTD, P.O. Box 9262, Amarillo, TX 79105 047126 * * * * * (2) * * * Drug labeler code Firm name and address * * * * * 047126 Micro Beef Technologies LTD, P.O. Box 9262, Amarillo, TX 79105 * * * * * Dated: December 31, 2002. Steven D. Vaughn, Director, Office of New Animal Drug Evaluation, Center for Veterinary Medicine. [FR Doc. 03-359 Filed 1-8-03; 8:45 am]